National Aeronautics and Space Administration, Houston, TX.
Memorial Sloan Kettering Cancer Center, New York, NY.
Life Sci Space Res (Amst). 2020 Aug;26:97-104. doi: 10.1016/j.lssr.2020.03.008. Epub 2020 May 20.
BACKGROUND/OBJECTIVES: Exercise is a front-line countermeasure used to maintain astronaut health during long-duration spaceflight; however, reductions in metabolic health still occur. Accordingly, we evaluated serial changes in metabolic parameters in a spaceflight analog and evaluated the efficacy of exercise with or without the addition of low-dose testosterone treatment on mitigating adverse metabolic changes.
SUBJECTS/METHODS: Healthy young (<55 years) men were randomly assigned to one of three groups during 70-days of strict, diet controlled, 6° head-down bed rest: Control (CON, n=9), exercise plus testosterone countermeasure (TEX, n=8), or exercise countermeasure plus placebo (PEX, n=9). Basal metabolic rate (BMR), glucose tolerance, and insulin sensitivity were measured before, during, and after bed rest. Exercise energy expenditure and excess post-exercise oxygen consumption were measured in TEX and PEX subjects during bed rest.
Leptin decreased during bed rest (Pre to BR+0 changed from 6.9 ± 5.1, 5.8 ± 4.2, and 4.7 ± 4.1 to 7.9 ±3.6, 6.5 ± 4.6, and 4.1 ±3.0 ug• L for CON, PEX, and TEX respectively). Bed rest induced a decrease in BMR (Pre to BR57 changed from 1655 ± 212, 1629 ± 108, and 1706 ± 146 to 1476 ± 166, 1668 ± 142, and 1603 ± 132 kcal • day ± 95%CI for CON, PEX, and TEX respectively). Similarly, bed rest negatively affected glucose metabolism assessed by 2hr OGTT glucose (Pre to BR66 changed from 6.29 ± 0.72, 5.13 ± 0.72, and 5.87 ± 0.73 to 6.62 ± 0.72, 5.83 ± 0.72, and 7.08 ± 0.72 mmol • L ± 95%CI). Reambulation following bed rest positively affected glucose tolerance in CON (2hr OGTT glucose at BR+12: 5.3 ± 0.72, 6.42 ± 0.73, and 6.04 ± 0.73 mmol • L ± 95%CI). Testosterone protected against bed rest induced insulin resistance (HOMA-IR from Pre to BR+66 changed from 1.74 ± 0.54, 1.18 ± 0.55, and 1.45 ± 0.56 to 2.24 ± 0.56, 1.47 ± 0.54, and 1.07 ± 0.54).
This study confirmed that inactivity during 70 days of head-down bed rest adversely affects metabolic health. The daily exercise countermeasures were beneficial but not completely protective of bed rest induced decrements in metabolic health. Supplementary countermeasures such as testosterone may provide additional benefits not provided by exercise alone.
背景/目的:运动是在长期太空飞行中维持宇航员健康的一线对策;然而,代谢健康仍会下降。因此,我们评估了在模拟太空飞行中代谢参数的连续变化,并评估了运动(单独或加用低剂量睾酮治疗)对减轻代谢不良变化的疗效。
受试者/方法:健康的年轻(<55 岁)男性在 70 天严格的饮食控制、6°头低位卧床休息期间随机分为三组:对照组(CON,n=9)、运动加睾酮对策组(TEX,n=8)或运动对策加安慰剂组(PEX,n=9)。在卧床休息前、期间和之后测量基础代谢率(BMR)、葡萄糖耐量和胰岛素敏感性。在 TEX 和 PEX 受试者卧床休息期间测量运动能量消耗和运动后过量氧消耗。
瘦素在卧床休息期间下降(从 6.9 ± 5.1、5.8 ± 4.2 和 4.7 ± 4.1 到 7.9 ±3.6、6.5 ± 4.6 和 4.1 ±3.0 ug•L,CON、PEX 和 TEX 分别)。卧床休息导致 BMR 下降(从 1655 ± 212、1629 ± 108 和 1706 ± 146 到 1476 ± 166、1668 ± 142 和 1603 ± 132 kcal • day ± 95%CI,CON、PEX 和 TEX 分别)。同样,卧床休息对通过 2 小时 OGTT 葡萄糖评估的葡萄糖代谢产生负面影响(从 6.29 ± 0.72、5.13 ± 0.72 和 5.87 ± 0.73 到 6.62 ± 0.72、5.83 ± 0.72 和 7.08 ± 0.72 mmol • L ± 95%CI)。卧床休息后再活动对 CON 的葡萄糖耐量产生积极影响(BR+12 时的 2 小时 OGTT 葡萄糖:5.3 ± 0.72、6.42 ± 0.73 和 6.04 ± 0.73 mmol • L ± 95%CI)。睾酮可预防卧床休息引起的胰岛素抵抗(从 Pre 到 BR+66 的 HOMA-IR 从 1.74 ± 0.54、1.18 ± 0.55 和 1.45 ± 0.56 到 2.24 ± 0.56、1.47 ± 0.54 和 1.07 ± 0.54)。
这项研究证实,70 天头低位卧床休息期间的不活动会对代谢健康产生不利影响。每天的运动对策是有益的,但不能完全防止卧床休息引起的代谢健康下降。补充对策,如睾酮,可能提供运动单独提供的额外益处。